BAJAJ BROKING

Notification
No new Notification messages
Nisus Finance Services IPO is Open!
Apply for the Nisus Finance Services IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
mankind pharma limited stock

MANKIND PHARMA LIMITED Share Price

2596.15 37.14 (1.45%)
Dec 04 2024 03:30 PM Pharmaceuticals NSE: MANKIND

MANKIND PHARMA LIMITED Share Price Update

As of the latest trading session, MANKIND PHARMA LIMITED share price is currently at 2596.15, which is up by 37.14 from its previous closing. Today, the stock has fluctuated between 2552.95 and 2619.00. Over the past year, MANKIND PHARMA LIMITED has achieved a return of 33.01 %. In the last month alone, the return has been -6.30 %. Read More...

MANKIND PHARMA LIMITED Performance

Day Range

Low2552.95 High2619.00
2596.15

52 Week Range

Low 1821.00 High 2874.00
2596.15

MANKIND PHARMA LIMITED Share Price

15380

543904

MANKIND

img img img img
No Data Available

Open Price

2572.40

Prev. Close

2559.00

Volume (Shares)

360240.00

Total traded value

9352.37

Upper Circuit

3070.80

Lower Circuit

2047.20

Note: The current prices & values are delayed, Login to your account for live updates.

MANKIND PHARMA LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 103998.80
PE Ratio (TTM) 49.08
Book Value / Share 269.23
Beta 0.33
ROE 20.95%
EPS (TTM) 50.03
Dividend Yield 0.00%
Net Profit Qtr (Cr) 634.43

MANKIND PHARMA LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 2529.74
Operating Expense 1865.05
Net Profit 634.43
Net Profit Margin (%) 25.07
Earnings Per Share (EPS) 15.84
EBITDA 857.79
Effective Tax Rate (%) 21.80
Particulars JUN 2024 (Values in Cr)
Revenue 2403.26
Operating Expense 1920.72
Net Profit 513.49
Net Profit Margin (%) 21.36
Earnings Per Share (EPS) 12.82
EBITDA 667.03
Effective Tax Rate (%) 16.12
Particulars MAR 2024 (Values in Cr)
Revenue 1996.55
Operating Expense 1567.66
Net Profit 454.17
Net Profit Margin (%) 22.74
Earnings Per Share (EPS) 11.34
EBITDA 599.02
Effective Tax Rate (%) 16.02
Particulars DEC 2023 (Values in Cr)
Revenue 2358.57
Operating Expense 1849.45
Net Profit 487.07
Net Profit Margin (%) 20.65
Earnings Per Share (EPS) 12.16
EBITDA 670.34
Effective Tax Rate (%) 15.49
Particulars SEP 2023 (Values in Cr)
Revenue 2260.47
Operating Expense 1743.64
Net Profit 472.88
Net Profit Margin (%) 20.91
Earnings Per Share (EPS) 11.80
EBITDA 656.24
Effective Tax Rate (%) 22.28
Particulars MAR 2024 (Values in Cr)
Revenue 8558.51
Operating Expense 6706.09
Net Profit 1823.41
Net Profit Margin (%) 21.30
Earnings Per Share (EPS) 45.52
EBITDA 2451.08
Effective Tax Rate (%) 18.83
Particulars MAR 2023 (Values in Cr)
Revenue 8127.15
Operating Expense 6727.10
Net Profit 1248.26
Net Profit Margin (%) 15.35
Earnings Per Share (EPS) 31.16
EBITDA 1860.16
Effective Tax Rate (%) 20.12
Particulars MAR 2022 (Values in Cr)
Revenue 7486.22
Operating Expense 5818.59
Net Profit 1389.42
Net Profit Margin (%) 18.55
Earnings Per Share (EPS) 34.68
EBITDA 2041.88
Effective Tax Rate (%) 25.75
Particulars MAR 2021 (Values in Cr)
Revenue 5523.18
Operating Expense 4237.46
Net Profit 1084.37
Net Profit Margin (%) 19.63
Earnings Per Share (EPS) 27.07
EBITDA 1526.38
Effective Tax Rate (%) 24.70
Particulars MAR 2024 (Values in Cr)
Book Value / Share 233.73
ROE % 23.12
ROCE % 27.91
Total Debt to Total Equity 0.02
EBITDA Margin 27.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 185.61
ROE % 19.27
ROCE % 23.11
Total Debt to Total Equity 0.08
EBITDA Margin 23.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 153.65
ROE % 26.72
ROCE % 33.43
Total Debt to Total Equity 0.10
EBITDA Margin 28.29
Particulars MAR 2021 (Values in Cr)
Book Value / Share 117.88
ROE % 31.51
ROCE % 39.19
Total Debt to Total Equity 0.05
EBITDA Margin 29.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 87.00
ROE % 30.30
ROCE % 39.51
Total Debt to Total Equity 0.04
EBITDA Margin 26.60
Particulars MAR 2024 (Values in Cr)
Book Value / Share 240.24
ROE % 20.95
ROCE % 25.77
Total Debt to Total Equity 0.00
EBITDA Margin 27.98
Particulars MAR 2023 (Values in Cr)
Book Value / Share 194.31
ROE % 17.43
ROCE % 20.91
Total Debt to Total Equity 0.05
EBITDA Margin 22.89
Particulars MAR 2022 (Values in Cr)
Book Value / Share 163.27
ROE % 24.65
ROCE % 31.42
Total Debt to Total Equity 0.07
EBITDA Margin 27.28
Particulars MAR 2021 (Values in Cr)
Book Value / Share 118.18
ROE % 25.86
ROCE % 33.63
Total Debt to Total Equity 0.01
EBITDA Margin 27.64
Particulars MAR 2020 (Values in Cr)
Book Value / Share 91.15
ROE % 28.53
ROCE % 36.39
Total Debt to Total Equity 0.03
EBITDA Margin 27.90
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1197.97
Total Assets 11963.25
Total Liabilities 11963.25
Total Equity 9575.78
Share Outstanding 400588440
Price to Book Ratio 9.56
Return on Assets (%) 15.98
Return on Capital (%) 19.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 453.19
Total Assets 9715.44
Total Liabilities 9715.44
Total Equity 7623.29
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 13.19
Return on Capital (%) 16.46
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 405.94
Total Assets 9147.73
Total Liabilities 9147.73
Total Equity 6316.31
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 15.67
Return on Capital (%) 19.95
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 700.74
Total Assets 6372.63
Total Liabilities 6372.63
Total Equity 4862.88
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 19.85
Return on Capital (%) 24.82
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 419.87
Total Assets 5073.28
Total Liabilities 5073.28
Total Equity 3671.57
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 20.31
Return on Capital (%) 27.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 761.01
Total Assets 11417.71
Total Liabilities 11417.71
Total Equity 9623.80
Share Outstanding 400588440
Price to Book Ratio 9.56
Return on Assets (%) 15.97
Return on Capital (%) 18.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 155.15
Total Assets 9371.12
Total Liabilities 9371.12
Total Equity 7783.91
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 13.32
Return on Capital (%) 16.04
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 138.84
Total Assets 8938.70
Total Liabilities 8938.70
Total Equity 6540.45
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 15.54
Return on Capital (%) 19.23
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 476.94
Total Assets 5880.33
Total Liabilities 5880.33
Total Equity 4734.27
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 18.44
Return on Capital (%) 22.45
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 197.94
Total Assets 4531.10
Total Liabilities 4531.10
Total Equity 3651.45
Share Outstanding 400588440
Price to Book Ratio 0.00
Return on Assets (%) 21.14
Return on Capital (%) 26.24
Particulars MAR 2024 (Values in Cr)
Net Income 2399.35
Cash from Operations 2631.97
Cash from Investing -2081.69
Cash from Financing 5.26
Net change in Cash 76.02
Free Cash Flow 2947.31
Particulars MAR 2023 (Values in Cr)
Net Income 1671.23
Cash from Operations 2136.39
Cash from Investing -1054.12
Cash from Financing -739.72
Net change in Cash 19.44
Free Cash Flow 2925.41
Particulars MAR 2022 (Values in Cr)
Net Income 1974.60
Cash from Operations 1419.28
Cash from Investing -1369.14
Cash from Financing 604.62
Net change in Cash 155.25
Free Cash Flow 1884.15
Particulars MAR 2021 (Values in Cr)
Net Income 1691.61
Cash from Operations 1591.31
Cash from Investing -1222.21
Cash from Financing -7.81
Net change in Cash -92.77
Free Cash Flow 1896.73
Particulars MAR 2020 (Values in Cr)
Net Income 1437.73
Cash from Operations 1400.61
Cash from Investing -439.15
Cash from Financing -530.73
Net change in Cash 99.81
Free Cash Flow 1603.42
Particulars MAR 2024 (Values in Cr)
Net Income 2259.56
Cash from Operations 2380.52
Cash from Investing -1919.11
Cash from Financing -8.68
Net change in Cash 55.17
Free Cash Flow 2569.43
Particulars MAR 2023 (Values in Cr)
Net Income 1562.83
Cash from Operations 2084.05
Cash from Investing -1040.61
Cash from Financing -710.41
Net change in Cash 47.96
Free Cash Flow 2632.41
Particulars MAR 2022 (Values in Cr)
Net Income 1871.43
Cash from Operations 1281.66
Cash from Investing -1360.26
Cash from Financing 578.62
Net change in Cash 39.80
Free Cash Flow 1583.01
Particulars MAR 2021 (Values in Cr)
Net Income 1440.20
Cash from Operations 1380.75
Cash from Investing -1127.15
Cash from Financing 88.86
Net change in Cash -54.91
Free Cash Flow 1570.94
Particulars MAR 2020 (Values in Cr)
Net Income 1264.92
Cash from Operations 1233.73
Cash from Investing -395.67
Cash from Financing -558.91
Net change in Cash 5.01
Free Cash Flow 1399.22
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 33.57 3.18 447.69 37.54 / 77.70
BLISS GVS PHARMA LTD 163.60 20.48 1.70 1722.74 92.25 / 172.40
CIPLA LTD 1534.40 26.84 4.36 123920.06 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 406.85 141.27 4.12 1197.40 145.00 / 413.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 50.80 9.93 447.69 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.60 45.60 7.27 2167.14 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6597.95 128.14 24.28 16494.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 163.60 21.30 1.68 1722.74 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 2575.00
  • 26 Days 2582.10
  • 10 Days 2577.40
  • 50 Days 2583.70
  • 12 Days 2569.60
  • 100 Days 2469.90
  • 20 Days 2603.80
  • 200 Days 2232.10
2582.78
PIVOT
First Resistance 2613.57
Second Resistance 2668.13
Third Resistance 2698.92
First Support 2528.22
Second Support 2497.43
Third Support 2442.87
RSI 46.24
MACD -12.47
Commodity Channel Index (CCI) -48.28
ADX 14.67
Williams % R -71.20

Over 1 Month

down

-6.30

Over 3 Months

down

7.02

Over 6 Months

down

20.39

Over 1 Year

down

33.01

Over 3 Years

down

0.00

Over 5 Years

down

0.00

MANKIND PHARMA LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MANKIND PHARMA LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
2.85
Promoter Holdings
74.86
FII
12.36
DII
9.9
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ramesh Juneja Family Trust (held In The Name Of Ramesh Juneja, Managing Trustee) Shareholding of Promoter and Promoter Group 8.3352652E7 20.8
Rajeev Juneja Family Trust (held In The Name Of Rajeev Juneja, Managing Trustee) Shareholding of Promoter and Promoter Group 7.993052E7 19.95
Prem Sheetal Family Trust (held In The Name Of Arora Family Private Limited, Trustee) Shareholding of Promoter and Promoter Group 6.1755635E7 15.41
Sheetal Arora Shareholding of Promoter and Promoter Group 1.9277647E7 4.81
Puja Juneja Shareholding of Promoter and Promoter Group 1.1533906E7 2.88
Poonam Juneja Shareholding of Promoter and Promoter Group 1.0557626E7 2.64
Arjun Juneja Shareholding of Promoter and Promoter Group 8154463.0 2.04
Ramesh Juneja Shareholding of Promoter and Promoter Group 6855990.0 1.71
Rajeev Juneja Shareholding of Promoter and Promoter Group 6500021.0 1.62
Sbi Nifty Midcap 150 Index Fund Public Shareholding 5960754.0 1.49
Government Pension Fund Global Public Shareholding 4430353.0 1.11
Tata Aia Life Insurance Company Limited A/c Group Public Shareholding 4307829.0 1.08
Chanakya Juneja Shareholding of Promoter and Promoter Group 3896788.0 0.97
Eklavya Juneja Shareholding of Promoter and Promoter Group 3896788.0 0.97
Mishka Arora Shareholding of Promoter and Promoter Group 2955692.0 0.74
Ria Chopra Juneja Shareholding of Promoter and Promoter Group 1292884.0 0.32
Greesh Kumar Juneja Shareholding of Promoter and Promoter Group 0.0 0.0
Rajeev Juneja And Sons Huf (rajeev Juneja - Karta) Shareholding of Promoter and Promoter Group 0.0 0.0
R C Juneja And Sons Huf (ramesh Juneja- Karta) Shareholding of Promoter and Promoter Group 0.0 0.0
Kusum Lata Dua Shareholding of Promoter and Promoter Group 0.0 0.0
Mohit Vij Shareholding of Promoter and Promoter Group 0.0 0.0
Rekha Vij Shareholding of Promoter and Promoter Group 0.0 0.0
Yogi Raj Vij Shareholding of Promoter and Promoter Group 0.0 0.0
Viralika Arora Shareholding of Promoter and Promoter Group 0.0 0.0
Esha Arora Tewari Shareholding of Promoter and Promoter Group 0.0 0.0
Nidhi Arora Shareholding of Promoter and Promoter Group 0.0 0.0
Prabha Arora Shareholding of Promoter and Promoter Group 0.0 0.0
Prem Kumar Arora Shareholding of Promoter and Promoter Group 0.0 0.0
Gautam Madan Shareholding of Promoter and Promoter Group 0.0 0.0
Sanjay Madan Shareholding of Promoter and Promoter Group 0.0 0.0
Asha Madan Shareholding of Promoter and Promoter Group 0.0 0.0
Ashok Kumar Shareholding of Promoter and Promoter Group 0.0 0.0
Geeta Agarwal Shareholding of Promoter and Promoter Group 0.0 0.0
Rajeev Mohan Agarwal Shareholding of Promoter and Promoter Group 0.0 0.0
Pushpa Rani Aggarwal Shareholding of Promoter and Promoter Group 0.0 0.0
Ayushi Juneja Sikri Shareholding of Promoter and Promoter Group 0.0 0.0
Wellspur Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Acche Karam Hospitality Llp Shareholding of Promoter and Promoter Group 0.0 0.0
A To Z Packers Shareholding of Promoter and Promoter Group 0.0 0.0
Anm Holdings Pte Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Casablanca Pharma Pte Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Salute Bestochem Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Petal Pharma Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Biovein Innovative Solutions Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Bigbrother Nutra Care Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Besto Herbs Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Quality Bestochem Formulations Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
G.a. Davai India Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Bestochem Formulations (india) Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Virmish Enterprises Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Teen Murti Products Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Star Infra Developers Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Saburi Sai Ram Buildtech Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Saburi Projects Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Saburi Enterprises Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Saburi Consultants Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Rpj Trustee Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Rotokind Technologies Shareholding of Promoter and Promoter Group 0.0 0.0
Rcj Advisors Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Rashmi Exports Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Rashi Apparels Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Printman Shareholding of Promoter and Promoter Group 0.0 0.0
Pp & A Combines Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Pathkind Diagnostics Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Paonta Process Equipments Shareholding of Promoter and Promoter Group 0.0 0.0
Om Sai Pharma Pack Shareholding of Promoter and Promoter Group 0.0 0.0
Nextwave India Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Mankind Drugs Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Mankind Biotech Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Multiventures Private Limited (formerly Known As Mankind Biosys Private Limited) Shareholding of Promoter and Promoter Group 0.0 0.0
Luxor Metaltec (india) Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
J & A Partners Shareholding of Promoter and Promoter Group 0.0 0.0
Intercity Corporate Towers Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Gyan Infrastructure Company Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Casablanca Securities Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Casablanca Pharma Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Casablanca Lifesciences Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Beckon Realestate Developers Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Ayushi And Poonam Estates Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Arora Family Pvt Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Projects Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Buildwell Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Buildrise Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Buildheights Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Appian Associates Infrastructure Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Anm Properties Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Alankrit Handicrafts Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Ajs Properties Shareholding of Promoter and Promoter Group 0.0 0.0
Ace Overseas Ventures Shareholding of Promoter and Promoter Group 0.0 0.0

MANKIND PHARMA LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About MANKIND PHARMA LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MANKIND PHARMA LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Mankind Pharma Ltd?

Answer Field

The share price of Mankind Pharma Ltd for NSE is ₹ 2596.15 and for BSE is ₹ 2595.

What is the Market Cap of Mankind Pharma Ltd?

Answer Field

The market cap of Mankind Pharma Ltd for NSE is ₹ 10,39,98.80 Cr. and for BSE is ₹ 10,39,52.70 Cr. as of now.

What is the 52 Week High and Low of Mankind Pharma Ltd?

Answer Field

The 52 Week High and Low of Mankind Pharma Ltd for NSE is ₹ 2874.00 and ₹ 1821.00 and for BSE is ₹ 2882.75 and ₹ 1820.15.

How to Buy Mankind Pharma Ltd share?

Answer Field

You can trade in Mankind Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Mankind Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 33.01%.

What is the Current Share Price of Mankind Pharma Ltd?

Answer Field

Mankind Pharma Ltd share price is for NSE ₹ 2596.15 & for BSE ₹ 2595 as on Dec 04 2024 03:30 PM.

What is the Market Cap of Mankind Pharma Ltd Share?

Answer Field

The market cap of Mankind Pharma Ltd for NSE ₹ 10,39,98.80 & for BSE ₹ 10,39,52.70 as on Dec 04 2024 03:30 PM.

What is the P/E Ratio of Mankind Pharma Ltd Share?

Answer Field

As on Dec 04 2024 03:30 PM the price-to-earnings (PE) ratio for Mankind Pharma Ltd share is 49.08.

What is the PB ratio of Mankind Pharma Ltd Share?

Answer Field

As on Dec 04 2024 03:30 PM, the price-to-book (PB) ratio for Mankind Pharma Ltd share is 269.23.

How to Buy Mankind Pharma Ltd Share?

Answer Field

You can trade in Mankind Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Mankind Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Mankind Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Mankind Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader